- ►annals.org SR Salpeter, NS Buckley, TM Ormiston, EE … - Annals of internal medicine, 2006 - Am Coll Physicians Add to CiteULike Add to Complore Add to Connotea Add to Del.icio.us Add to Digg
Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this? ...
Background: Long-acting ß-agonists may increase the risk for fatal and ... Cited by 203 - Related articles - BL Direct - All 11 versions
- ►nih.gov SR Salpeter, NS Buckley, EE Salpeter - Journal of General Internal Medicine, 2006 - Springer BAGRO[TND: Anticholinergics and 2-agonists have generally been considered
equivalent choices for bronchodilation in chronic obstruc- tive pulmonary
disease (COPD). OBJECTIVE; To assess the safety and efficacy of ... Cited by 96 - Related articles - BL Direct - All 12 versions
- ►annals.org SE Weinberger, LG Smith, VU Collier… - Annals of internal medicine, 2006 - Am Coll Physicians A more recent version of this article appeared on June 20, 2006. ...
Background: Long-acting ß-agonists may increase the risk for fatal and nonfatal
asthma exacerbations. ... Purpose: To assess the risk for severe, life- ... Cited by 63 - Related articles - BL Direct - All 6 versions
- ►critcaremed.org SR Salpeter - Drugs &# 38; Aging, 2004 - ingentaconnect.com Background: β 2 -Adrenoceptor agonists have been used as bronchodilators in the
Abstract management of asthma and chronic obstructive pulmonary disease (COPD);
however, there is evidence suggesting that β 2 -adrenoceptor agonist use ... Cited by 37 - Related articles - BL Direct - All 5 versions
S Haney, RJ Hancox - Respiratory medicine, 2005 - Elsevier Methods: Ten subjects with stable asthma were studied. Following 2 weeks without
beta-agonists, methacholine was inhaled to induce a 20% reduction in FEV 1 . The
response to inhaled salbutamol (100, 100, 200 μg at 5-min intervals) was ... Cited by 29 - Related articles - All 14 versions
- ►ersjournals.com MA Giembycz, R Newton - European Respiratory Journal, 2006 - Eur Respiratory Soc This classical model of ß 2 -adrenoceptor-mediated signal transduction is
deeply entrenched, but there is compelling evidence that agonism of ß 2
-adrenoceptors can lead to the activation of multiple effector pathways, ... Cited by 30 - Related articles - BL Direct - All 6 versions
J Hasford, JC Virchow - European Respiratory Journal, 2006 - ersj.org.uk Asthma ranks among the most common of chronic diseases in the Western world.
Although modern therapy has improved patient care, asthma still affects 5–10%
of the population and, according to the World Health Organization, claims ... Cited by 20 - Related articles - BL Direct - All 6 versions
- ►tmc.edu [PDF] NA Hanania, S Singh, R El-Wali, M Flashner, … - Pulmonary pharmacology & therapeutics, 2008 - Elsevier Beta-blockers are currently contraindicated in asthma because their acute
administration may be associated with worsening bronchospasm. However, their
effects and safety with their chronic administration are not well ... Cited by 18 - Related articles - All 6 versions
- ►atsjournals.org J Oostendorp, DS Postma, H Volders, H … - American journal of respiratory and critical care …, 2005 - Am Thoracic Soc Single-nucleotide polymorphisms of the ß 2 -adrenergic receptor gene and its 5'
promoter have been associated with differences in receptor function and
desensitization. Linkage disequilibrium may account for inconsistencies in ... Cited by 15 - Related articles - BL Direct - All 7 versions
